Menopause & midlife

HRT and Dementia Risk: What Studies Show

Save

Hormone therapy is not a proven way to prevent dementia, and starting it after age 65 may raise risk. In older women, estrogen plus progestin roughly doubled dementia risk in one trial; in women who start near menopause, studies show neither clear benefit nor harm. Guidelines do not recommend it for the brain.

Last updated: July 2026History

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does hormone therapy prevent dementia?

No high-quality trial has shown that hormone therapy prevents dementia or Alzheimer's disease. Early observational studies hinted at protection, but randomized trials did not confirm it. According to the North American Menopause Society, hormone therapy is not recommended at any age to prevent cognitive decline, and the window in which it appears safe for other reasons is generally under 60 or within 10 years of menopause 1. That leaves symptom relief, not brain protection, as the reason to consider it. Setting this expectation early prevents disappointment and unnecessary risk. The wider hormone therapy decision rests on symptoms and personal risk rather than on any promise about memory.

What did the WHI Memory Study find?

The Women's Health Initiative Memory Study tested estrogen plus progestin in women aged 65 and older and found more dementia, not less. In that trial, combined hormone therapy roughly doubled the risk of dementia, an increase of about 23 more cases for every 10,000 women each year 2. The women were well past menopause, and their older brains appear central to the harm. This is the strongest signal that starting hormones late is the wrong time for cognition. It does not describe what happens when treatment begins near menopause, which is a different situation entirely.

Is it different when you start near menopause?

Starting hormone therapy around the time of menopause looks different from starting it in the mid-60s. In the KEEPS cognitive study, recently postmenopausal women, on average about 52 years old, showed neither cognitive benefit nor harm from hormone therapy over roughly 4 years 3. That is reassuring for women who take hormones for symptoms, but it is not evidence of protection. Much of the brain fog of this life stage is tied to disrupted sleep, hot flashes, and mood, and it often eases on its own. Near-menopause treatment appears cognitively neutral, which is a fair and honest expectation to hold.

How do age and the transition shape brain symptoms?

Memory complaints are common during the perimenopausal transition and usually differ from dementia. Many women in their 40s and early 50s notice word-finding trouble or fuzzy concentration, according to menopause guidance, and these transient changes are linked to sleep loss, vasomotor symptoms, and mood shifts in perimenopause rather than to a progressive disease 4. Symptoms that steadily worsen or disrupt daily life are a different matter and deserve evaluation; distinguishing normal memory changes in your 50s from dementia is exactly the kind of question worth asking. Unlike late-life dementia, the transition's fog is usually temporary 5.

When memory changes deserve a clinician's eye

A clinician can separate the fog of the menopause transition from memory problems that need a workup. A menopause clinician or primary care clinician can review sleep, mood, thyroid, medications, and symptoms, and refer to neurology when a pattern suggests more than the transition. The same visit can cover whether hormone therapy fits your symptoms and how it relates to other questions, such as its effect on the heart. Gale can help you note what you are noticing and prepare questions before that conversation.

Common questions

No trial has shown that it does, and guidelines do not recommend hormone therapy to prevent cognitive decline or Alzheimer's at any age. Early observational hints of protection were not confirmed when tested in randomized trials.

Starting combined hormone therapy after age 65 raised dementia risk in a large trial. Starting near menopause for symptoms appears cognitively neutral in the studies done so far, which is why age at initiation matters so much in this conversation.

Brain fog in the transition is common and usually tied to poor sleep, hot flashes, and mood changes rather than a lasting problem. It tends to ease over time and is different from the steady decline seen in dementia.

Memory changes that steadily worsen, disrupt daily tasks, or come with confusion or getting lost deserve a medical evaluation. A clinician can tell apart the temporary fog of menopause from problems that need a fuller workup.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Memory changes worth checking

  • —New confusion, getting lost in familiar places, or trouble managing money is a reason to seek clinician review
  • —Memory loss that disrupts daily life or steadily worsens is a reason to seek a medical evaluation
  • —A sudden change in memory, speech, or coordination is a reason to seek emergency care right away
  • —Thoughts of self-harm during a low mood are a reason to reach the 988 Suicide and Crisis Lifeline and seek clinician support

This article is general health education, not medical advice. Whether memory changes reflect the menopause transition or something that needs a workup is best assessed by a menopause clinician, primary care clinician, or neurologist.

Did this answer your question?

References

  1. 1.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Menopause society position that hormone therapy is not recommended at any age to prevent cognitive decline, and that its safer window is generally under 60 or within 10 years of menopause.
  2. 2.Shumaker SA, Legault C, Rapp SR, et al. / Women's Health Initiative Memory Study (WHIMS) (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. doi:10.1001/jama.289.20.2651 ✓The WHI Memory Study showing estrogen plus progestin roughly doubled dementia risk in women aged 65 and older, about 23 additional cases per 10,000 women per year.
  3. 3.Gleason CE, Dowling NM, Wharton W, et al. (2015). Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-Cognitive and Affective Study. PLoS Medicine. doi:10.1371/journal.pmed.1001833 ✓The KEEPS-Cognitive study showing neither cognitive benefit nor harm from hormone therapy in recently postmenopausal women (average age about 52) over roughly 4 years.
  4. 4.World Health Organization (2024). Menopause (fact sheet). World Health Organization (WHO). link ✓Overview of the menopause transition, including that cognitive and mood symptoms are common features of perimenopause.
  5. 5.MedlinePlus (National Library of Medicine) (2026). Hormone Replacement Therapy. MedlinePlus, U.S. National Library of Medicine (NIH). link ✓Patient-facing overview of hormone therapy and the menopause transition, including that transition symptoms are typically temporary.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library